title: Ambulatory infusional cancer chemotherapy: nursing role in patient management. The Cancer Center of Boston.
abstract: The role of nursing in infusional cancer chemotherapy (ICC) may vary depending on the practice setting. Nurses in free-standing centers and office practices perform many duties that nurses in other facilities may not, because of the lack of many of the supports that benefit hospitals with their multidepartmental and hierarchical structures. Nurses function collaboratively with physicians in the planning and the implementation of patient treatment. Patient-related nursing responsibilities include patient/family education, drug preparation and administration, patient assessment for treatment toxicity, recognition and management of complications related to the catheter or infusion device, and telephone triage. Other duties more removed from patient care might include inventory management, research data collection and management, quality assurance and improvement, compliance with regulatory issues, and a myriad of other responsibilities. The transition of patient care to the outpatient setting has broadened the scope of nursing to include nonpatient care responsibilities due to financial constraints brought about by health care reform, changes in reimbursement patterns, and overhead required to maintain and deliver quality patient care. As a result of nursing responsibilities, it becomes paramount that the aforementioned constructs for program support are in place and that all nurses are consistently trained and have a template to follow for patient treatment and management. Nursing ability to perform patient-related tasks should be proven by formal written and practical competencies repeated annually and as procedural changes are implemented. The paragraphs to follow suggest nursing management of patients receiving ICC using a model developed at The Cancer Center of Boston (TCC).
authors.affiliation: Cancer Center of Boston, Massachusetts, USA.
authors.forename: C
authors.initials: C
authors.lastname: Moore
authors.forename: D
authors.initials: D
authors.lastname: Strong
authors.forename: J
authors.initials: J
authors.lastname: Childress
authors.forename: B
authors.initials: B
authors.lastname: Fougere
authors.forename: S
authors.initials: S
authors.lastname: Gotthardt
mesh_terms: D000553:Ambulatory Care / Q000458:organization & administration*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001900:Boston; D002173:Cancer Care Facilities / Q000458:organization & administration; D004334:Drug Administration Schedule; D005568:Forms and Records Control; D006801:Humans; D007262:Infusions, Intravenous / Q000451:nursing; D008962:Models, Theoretical; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing; D009503:Neutropenia / Q000139:chemically induced / Q000451:nursing; D009723:Nurse-Patient Relations; D009732:Nursing Care; D009737:Nursing Records; D010353:Patient Education as Topic
chemical_list: D000970:Antineoplastic Agents